Amylyx Pharmaceuticals Inc (AMLX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Amylyx Pharmaceuticals Inc Stock (AMLX) Company Profile

Amylyx Pharmaceuticals Inc

Healthcare (1104)

617-682-0917

55 CAMBRIDGE PARKWAY, CAMBRIDGE

Prossima data di guadagno

Ultimi documenti SEC

AMLX's Discussions on Twitter

Compare AMLX vs TAK, HLN, TEVA, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AMLX Amylyx Pharmaceuticals Inc	15.67	1.74B	-665.00K	-150.11M	-124.53M	-1.5071
TAK Takeda Pharmaceutical Co Adr	15.63	49.39B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	8.96	39.55B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.48	36.66B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	78.71	33.00B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	536.59	22.78B	3.17B	1.29B	1.01B	27.09

Amylyx Pharmaceuticals Inc Stock (AMLX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-03	Iniziato	Stifel	Buy
2025-07-10	Ripresa	Goldman	Buy
2025-06-24	Iniziato	Guggenheim	Buy
2025-06-17	Iniziato	Citigroup	Buy
2025-05-30	Iniziato	TD Cowen	Buy
2025-04-07	Aggiornamento	Mizuho	Neutral → Outperform
2024-11-18	Aggiornamento	Robert W. Baird	Neutral → Outperform
2024-10-23	Aggiornamento	BofA Securities	Neutral → Buy
2024-03-18	Downgrade	Mizuho	Buy → Neutral
2024-03-11	Downgrade	Leerink Partners	Outperform → Market Perform
2024-03-11	Downgrade	Robert W. Baird	Outperform → Neutral
2024-03-08	Downgrade	Evercore ISI	Outperform → In-line
2024-03-08	Downgrade	Goldman	Buy → Neutral
2024-01-03	Iniziato	Robert W. Baird	Outperform
2023-12-12	Iniziato	Deutsche Bank	Buy
2023-07-24	Aggiornamento	Goldman	Neutral → Buy
2023-03-31	Iniziato	Mizuho	Buy
2023-01-05	Iniziato	BofA Securities	Buy
2022-05-25	Iniziato	Citigroup	Buy
2022-04-01	Downgrade	Goldman	Buy → Neutral

Mostra tutto

Amylyx Pharmaceuticals Inc Borsa (AMLX) Ultime notizie

Amylyx Pharmaceuticals Inc Azioni (AMLX) Dati Finanziari

Amylyx Pharmaceuticals Inc (AMLX)

Amylyx Pharmaceuticals Inc Stock (AMLX) Company Profile

Compare AMLX vs TAK, HLN, TEVA, ZTS, UTHR

Amylyx Pharmaceuticals Inc Stock (AMLX) Upgrades & Downgrades

Amylyx Pharmaceuticals Inc Borsa (AMLX) Ultime notizie

Amylyx Pharmaceuticals Inc (AMLX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Amylyx Pharmaceuticals Inc (AMLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Amylyx Pharmaceuticals Inc (AMLX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Amylyx Pharmaceuticals Inc (AMLX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Amylyx Pharmaceuticals Inc (AMLX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Amylyx Pharmaceuticals Inc (AMLX) Institutional Confidence - TradingKey

Amylyx Pharmaceuticals Inc (AMLX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Amylyx Pharmaceuticals Inc (AMLX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Amylyx Pharmaceuticals Inc (AMLX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Amylyx Pharmaceuticals eyes Q3 phase 3 Avexitide readout as PBH launch plans take shape - MSN

Amylyx Pharmaceuticals Eyes Q3 Phase 3 Avexitide Readout as PBH Launch Plans Take Shape - Yahoo Finance

Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026 - BioSpace

Amylyx (NASDAQ: AMLX) director receives 24,372 stock options grant - Stock Titan

Amylyx (AMLX) director Karen Firestone receives 24,372 stock options grant - Stock Titan

Amylyx (NASDAQ: AMLX) director receives 24,372-share stock option grant - Stock Titan

Amylyx (NASDAQ: AMLX) director awarded 24,372 stock options at $14.31 strike - Stock Titan

Amylyx (AMLX) director Paul Fonteyne receives grant of 24,372 stock options - Stock Titan

Claim your share of the $6.5M Amylyx Pharmaceuticals securities class action settlement - Claim Depot

Post-bariatric hypoglycemia toll, avexitide trial design at ENDO 2026 - Stock Titan

H.C. Wainwright reiterates Amylyx stock rating on PBH trial insights By Investing.com - Investing.com South Africa

H.C. Wainwright reiterates Amylyx stock rating on PBH trial insights - Investing.com

Amylyx earnings on deck ahead of pivotal avexitide trial data By Investing.com - Investing.com Nigeria

Amylyx Pharmaceuticals eyes phase 3 AVEXITIDE readout as 2027 launch comes into focus - MSN

Amylyx Pharmaceuticals (NASDAQ: AMLX) investors approve directors, auditor and say-on-pay - Stock Titan

A Look At Amylyx Pharmaceuticals (AMLX) Valuation After Its Recent Share Price Rebound - Yahoo Finance

AMLX Stock Price, Quote & Chart | AMYLYX PHARMACEUTICALS INC (NASDAQ:AMLX) - ChartMill

Amylyx Pharmaceuticals (AMLX) Gains 3.36% as Shares Approach ResistanceWatchlist Stock Ideas - thelegaladvocate.com

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biohaven Ltd. (BHVN) and Immix Biopharma (IMMX) - The Globe and Mail

Amylyx director Karen Firestone purchases $51,338 of common stock. By Investing.com - Investing.com Nigeria

Amylyx director Karen Firestone purchases $51,338 of common stock. - Investing.com

Director Karen Firestone adds Amylyx Pharmaceuticals (AMLX) shares - Stock Titan

Amylyx gets FDA fast track status for ALS treatment - MSN

Amylyx Pharmaceuticals (AMLX) Slips 2.5% as Biotech Sector Faces Renewed ScrutinyAAII Bullish - thelegaladvocate.com

Amylyx Stock: Why the Full Pipeline Story Matters - MarketBeat

Guggenheim Initiates Coverage of Amylyx Pharmaceuticals (AMLX) with Buy Recommendation - MSN

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer FRATES JAMES M - Moomoo

Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 2026 Results and Pipeline Progress - Insider Monkey

Amylyx Pharmaceuticals, Inc.Common Stock (NQ: AMLX - FinancialContent

Mizuho Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $21 - Moomoo

Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation - BioSpace

Teva Pharmaceutical (TEVA) Reports Q1 Beat, Plans Amylyx Deal - Yahoo Finance

Number of shareholders of Amylyx Pharmaceuticals, Inc. – BOATS:AMLX - TradingView

Perceptive group holds 8.28M shares of Amylyx (AMLX) in Schedule 13G/A - Stock Titan

Amylyx publishes phase 2 Wolfram syndrome trial results - Investing.com

Amylyx Pharmaceuticals Inc Azioni (AMLX) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a AMLX